home / stock / kne:cc / kne:cc news

KNE:CC News and Press, Kane Biotech Inc.

Stock Information
Company Name: Kane Biotech Inc.
Stock Symbol: KNE:CC
Market: TSXVC
Website: kanebiotech.com
Menu
KNE:CC KNE:CC Quote KNE:CC Short KNE:CC News KNE:CC Articles KNE:CC Message Board
Get KNE:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
KNE:CC - Kane Biotech Receives FDA Approval to Increase Dosage Allowance of its revyve(TM) Antimicrobial Wound Gel

WINNIPEG, Manitoba, July 23, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) announces that the US Food and Drug Administration (FDA) has eliminated its usage limitation on the Company’...
KNE:CC - Kane Biotech Receives ISO 13485:2016 MDSAP Quality Certification

WINNIPEG, Manitoba, July 17, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has received ISO 13485:2016 Medical Device Single Audit Program (“MDSAP”) Quality Certification as a designer, de...

KNE:CC - Kane Biotech Signs Worldwide License Agreement with Omni Bioceutical Innovations Inc.

WINNIPEG, Manitoba, July 11, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has signed a worldwide license agreement with Arizona-based Omni Bioceutical Innovations Inc. (“Omni”) for its c...

KNE:CC - Kane Biotech Makes First Commercial Sale of revyve(TM) Antimicrobial Wound Gel to ProgenaCare Global

WINNIPEG, Manitoba, June 27, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has made its first commercial-scale sale of revyve™ Antimicrobial Wound Gel product (“revyve™”...
KNE:CC - Kane Biotech Signs Worldwide License Agreement with Montreal-Based I-MED Pharma Inc.

WINNIPEG, Manitoba, June 25, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has entered into a worldwide license agreement with I-MED Pharma Inc. (“I-MED Pharma” or “I-MED”) ...

KNE:CC - Kane Biotech Announces First Quarter 2024 Financial Results

WINNIPEG, Manitoba, May 23, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces its first quarter 2024 financial results. The Company previously announced on April 11, 2024 that it had reached an ...

KNE:CC - Expected Canadian Company Earnings on Thursday, May 23rd, 2024

Silvercorp Metals Inc. (SVM:CA) is expected to report $0.03 for Q4 2024 NeutriSci International Inc. (NU.H:CA) is expected to report for Q1 2024 Abcourt Mines Inc. (ABI:CA) is expected to report for Q3 2024 Corsa Coal Corp. (CSO:CA) is expected to report for Q1 2024 Urbanfund Corp...
KNE:CC - Kane Biotech to Release First Quarter 2024 Financial Results on May 23, 2024

WINNIPEG, Manitoba, May 16, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove m...

KNE:CC - Kane Biotech Expands its Wound Care Portfolio with Patented Schultz Biofilm Wound Map

WINNIPEG, Manitoba, May 15, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company”, “Kane” or “Kane Biotech”) announces its intent to commercialize the patented assay which is to be named the Schultz Biofilm Wound Map in honou...

KNE:CC - Canadian Companies Moving the Markets, Morning edition
Wed, Apr 17, 2024 as of 10.00 am ET

A look at the top 10 most actives in Canada BMO Long Federal Bond Index ETF (ZFL) rose 0.2% to $12.35 on volume of 10,056,021 shares Delta 9 Cannabis Inc. (DN) fell 16.7% to $0.025 on volume of 6,264,289 shares BMO Equal Weight Banks Index ETF (ZEB) rose 0.7% to $35.61 on volume of 4,183,...
Next 10